Patent Assignment
Reel/Frame 056583/0647
Corrective Assignment to Correct the Nature of Conveyance and Assignor's Name Previously Recorded on Reel 022390 Frame 0234. Assignor(S) Hereby Confirms the Change of Name.
Recorded: 2021-05-26
Pages: 9
Assignor
KYOWA HAKKO KOGYO CO., LTD.
Executed: 2008-10-01
Assignee
KYOWA HAKKO KIRIN CO., LTD.
1-6-1 OHTEMACHI, CHIYODA-KU, TOKYO, JAPAN
Covered Properties
(34)
Spicamycin Derivatives and Their Use as Anticancer Agents
Patent:
5,461,036 →
Application:
07/910,640 →
Spicamycin Derivatives and the Use Thereof
Patent:
5,631,238 →
Application:
08/429,303 →
A-Galactosylceramide Derivatives
Patent:
5,936,076 →
Application:
08/450,109 →
Rho Target Protein Rho-Kinase
Patent:
5,906,819 →
Application:
08/685,576 →
Rho Target Protein Kinase P160
Patent:
6,013,499 →
Application:
08/685,871 →
Chimeric Mice That Are Produced by Microcell Mediated Chromosome Transfer and That Retainn a Human Antibody Gene
Patent:
6,632,976 →
Application:
09/033,936 →
Calcium Receptor Active Compounds
Patent:
6,362,231 →
Application:
09/214,552 →
Nkt Cell Activators Containing Alpha-Glycosylceramides
Patent:
6,531,453 →
Application:
09/402,785 →
Process for Producing Quinolone Derivatives
Patent:
6,187,926 →
Application:
09/420,521 →
Method for Modifying Chromosomes
Patent:
7,371,568 →
Application:
09/763,362 →
Stem Cell Growth Factor-Like Polypeptide
Patent:
6,667,391 →
Application:
09/764,325 →
Human Anti-CD40 Antibodies
Quinoline Derivatives and Quinazoline Derivatives
Patent:
6,797,823 →
Application:
09/889,858 →
Method of Promoting Stem Cell Proliferation or Survival by Contacting a Cell with a Cell Factor-Like Polypeptide
Stem Cell Growth Factor-Like Polypeptides
Transgenic Bovine Comprising Human Immunoglobulin Loci and Producing Human Immunoglobulin
Transgenic Transchromosomal Rodents for Making Human Antibodies
Calcium Receptor-Active Compounds
Quinoline Derivatives and Quinazoline Derivatives Having Azolyl Group
Polynucleotides Encoding Stem Cell Growth Factor-Like Polypeptides
Nitrogen-Containing Compounds Having Kinase Inhibitory Activity and Drugs Containing the Same
Novel Isoxazole and Thiazole Compounds and Use Thereof as Medicine
Calcium Receptor-Active Compounds
Nkt Cell-Activating Agents Containing Alpha-Glycosylceramides
Transgenic Bovines Capable of Human Antibody Production
Polypeptide Having an Activity to Support Proliferation or Survival of Hematopoietic Stem Cell and Hematopoietic Progenitor Cell, and Dna Coding for the Same
Polypeptide Having an Activity to Support Proliferation or Survival of Hematopoietic Stem or Progenitor Cells
N-{2-Chloro-4-[(6,7-Dimethoxy-4-Quinolyl)Oxy]Phenyl}-N'-(5-Methyl-3-Isoxazolyl)Urea Salt in Crystalline Form
Quinoline Derivatives and Quinazoline Derivatives
Quinoline Derivatives and Quinazoline Derivatives Having Azolyl Group
Stem Cell Growth Factor-Like Polypeptides
Transgenic Animals and Uses Thereof
Human Artificial Chromosome Containing Human Antibody Lambda Light Chain Gene and Non-Human Animal Containing the Human Artificial Chromosome Capable of Genetic Transmission
Anti-A33 Antibody
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger
May 7, 2014
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 032836/0160 →
Change of Name
Jan 12, 2015
From: SANFORD APPLIED BIOSCIENCES, L.L.C.
To: SAB, LLC
Reel/Frame 034751/0027 →
Merger
Jun 3, 2015
From: MEDAREX, L.L.C.
To: E. R. SQUIBB & SONS, L.L.C.
Reel/Frame 035775/0436 →
Change of Name and Address
Oct 23, 2019
From: KYOWA HAKKO KIRIN CO., LTD.
To: KYOWA KIRIN CO., LTD.
Reel/Frame 050797/0533 →
Merger
May 26, 2021
From: KIRIN PHARMA COMPANY, LIMITED (A/K/A KIRIN PHARMA KABUSHIKI KAISHA)
To: KYOWA HAKKO KOGYO CO., LTD.
Reel/Frame 056351/0089 →